garenoxacin has been researched along with cefdinir in 1 studies
| Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (cefdinir) | Trials (cefdinir) | Recent Studies (post-2010) (cefdinir) |
|---|---|---|---|---|---|
| 195 | 19 | 46 | 33 | 0 | 10 |
| Protein | Taxonomy | garenoxacin (IC50) | cefdinir (IC50) |
|---|---|---|---|
| SUMO-1 | Homo sapiens (human) | 6.25 | |
| low molecular weight phosphotyrosine protein phosphatase isoform c | Homo sapiens (human) | 19.6 | |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | 4.48 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Distèche-Nguyen, M; Gerards, T; Luxen, A; Miguet, L; Pasha, FA; Thomas, A; Zervosen, A | 1 |
1 other study(ies) available for garenoxacin and cefdinir
| Article | Year |
|---|---|
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
Topics: Computational Biology; Computer Simulation; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ligands; Penicillin-Binding Proteins; Protein Binding; Streptococcus pneumoniae; Structure-Activity Relationship | 2009 |